Ukraine should re-look at the development of nuclear power generation, including focusing on the implementation of projects that increase the ability to maneuver, acting Minister of Energy and Environmental Protection Olha Buslavets has said.
Commenting on the relevance of the Ukraine-EU Energy Bridge project in an interview with Interfax-Ukraine, she said that, in the context of the construction of new facilities, it is more advisable to focus on the construction of small modular reactors (SMR).
“The decisions on the energy bridge are related to the completion of reactors three and four of the Khmelnytsky NPP. My personal expert conviction: we need to reconsider what exactly needs to be developed in nuclear power generation. If we talk about new construction, we should talk about small modular reactors with the possibility of regulation. We already have a power system that is very overloaded with basic capacities. Energoatom is 55% of our electricity production, which, I will remind you, is not regulated,” she said.
In addition, Buslavets expressed the opinion that for Ukraine, which plans to synchronize with the European Network of Transmission System Operators for Electricity (ENTSO-E) by 2023, it would be more expedient to focus all its efforts on this project.
“When it [the energy bridge project] was only being worked out, I did not see the point in a separate project if there were plans for general synchronization with the European system. It would be more expedient to focus all efforts on general integration, rather than being distracted by some separate projects and give separate conditions,” the acting minister said.
Advisor to the President of Ukraine on Economics Oleh Ustenko took part in an online meeting with leading businessmen belonging to the CEO Club Ukraine, during which issues related to the development of the Ukrainian economy during the quarantine and the global economic crisis, as well as measures to minimize its negative impact for Ukraine were addressed.
“The presidential advisor answered questions of Ukrainian business, shared his forecasts and scenarios for the development of the economic situation in the country, noting that Ukraine has a good basis for rapid stabilization and growth after the coronavirus epidemic,” the presidential office’s press service said on Thursday.
Ustenko separately dwelt on the issue of adapting the economic strategy of Ukraine to the new operating conditions during the COVID-19 pandemic, assuring the business community that the economic system of the state is now under full control.
“Within the framework of the presidential anti-crisis policy, the government and parliament have already adopted two packages of anti-crisis measures, and now the third is being developed, which will include measures to protect businesses from the effects of the epidemic and the global crisis,” the report says.
Ustenko noted the need for everyone to remain, above all, humane during the crisis and not fall into despair.
“We are living in such a difficult time, but we must always remember that there is someone for whom it is much more difficult now. If you helped the weak, please continue to do so. Our financial opportunities during the crisis are reduced. However, it’s important to withdraw from this crisis cleaner and better, more humane and socially responsible,” he stressed.
The lifting of the moratorium on the sale of agricultural land is a significant impetus to the development of the economy, farming and the agro-industrial complex.
“The lifting of the moratorium on the sale of agricultural land is a significant impetus for the development of the economy, farming, the agricultural complex in Ukraine,” Prime Minister Denys Shmyhal said on Telegram.
As reported, on the night of March 31, the Verkhovna Rada at an extraordinary meeting adopted a law on opening the land market from July 1, 2021 with the restriction of its work in the first three years only to land plots owned by individuals with a maximum ownership of 100 hectares per capita.
The shareholders of PrJSC VF Ukraine (provides mobile services under the Vodafone-Ukraine brand) on January 20 decided to provide prior consent to raising funds of up to $1 billion, but the company plans to gradually raise up to $500 million from external sources for the implementation of the development strategy, the operator’s press service has told Interfax-Ukraine.
“At the moment, the company is considering its development strategy. In the near future, we are considering options for phased attraction of external financing in the range of $500 million,” Viktoria Ruban, the head of the public relations department of Vodafone-Ukraine, said.
According to her, attracting external financing on favorable terms is consistent with the company’s development strategy and is a common practice in business.
According to a company report in the information disclosure system of the National Commission for Securities and the Stock Market, the company was allowed to sign loan agreements, agreements on commissions, orders from other transactions related to raising funds. The limit amount of such transactions is $1 billion (or UAH 24.253 billion at the NBU rate as of January 20, 2020).
The value of the company’s assets as of 2018 stood at UAH 21.479 billion.
The ratio of the marginal aggregate of transaction value to the value of the issuer’s assets according to the latest annual financial statements is 112.91%.
Farmak pharmaceutical company (Kyiv) plans to invest UAH 1.2 billion in production development in 2020, which is 30% more than last year, and also increase the number of staff. According to the company’s press service, with reference to executive director of Farmak Volodymyr Kostiuk, in 2019 investments for these purposes amounted to UAH 900 million.
“In 2019, we invested about UAH 900 million in the development of production, in 2020 we plan to invest UAH 1.2 billion. The expansion of production leads to an increase in the number of personnel,” he said.
According to Kostiuk, the issue of personnel remains acute for the company.
“We create the most comfortable working conditions for specialists and provide competitive wages. Today we compete with European companies in terms of wages in relation to the average check in a particular country. In 2019, wages at Farmak increased by 14%,” he said.
The top manager also said that in 2019 Farmak expanded its cold, allergological, neurological, gastroenterological product portfolios and is working on complex drugs that it plans to bring to the market in 10-15 years.
The main areas remain cold, endocrinological, gastroenterological, cardiological, neurological portfolios.
The European Union has launched a project entitled “Support to Ukraine for Developing a Modern Public Health System” on December 12, the Public Health Center (PHC) reported. The project will help the government to implement public health reform in line with its obligations under the EU-Ukraine Association Agreement, reads the statement on the website of the PHC.
The experts will consult the Health Ministry of Ukraine, the PHC and the regional public health centers, help to draw up laws and regulations, analyze and implement the EU practices.
According to the statement, the project is aimed at streamlining the public health system in Ukraine with the EU practices, creating a sustainable epidemiology surveillance system to control contagious and non-contagious diseases and introducing the International Health Regulations to prevent, protect against, control and provide a public health response to the international spread of disease.
In addition, the project will provide support for reform of the blood donation service in Ukraine via the development of a modern blood safety system in line with the EU standards. The project will also help to improve the quality control system, create donor registers and unified standards for blood transfusion, promote voluntary blood donation and establish an independent competent agency in the sphere of blood safety.
The EU project “Support to Ukraine for Developing a Modern Public Health System” will be implemented from 2019 until 2022 by the GFA Consulting Group GmbH (GFA) in consortium with the National Institute for Health and Welfare, Finland (THL). The budget of the project is EUR 3 million.